Lu Jialin, Wang Kuang, Gao Zhihua, Zhang Songbo, Li Hao, Shi Yanqing, Song Xuecheng, Liu Jingze, Yu Zhijun, Yang Xiaolong
Hebei Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, China.
Front Vet Sci. 2022 Aug 10;9:872244. doi: 10.3389/fvets.2022.872244. eCollection 2022.
As obligate blood-feeding ectoparasites, ticks secrete a great diversity of antithrombin molecules during feeding. In this study, a novel antithrombin gene named was characterized from the tick . It has an open reading frame size of 426 bp; it encodes 141 amino acids and has a predicted molecular weight of 15.8 kDa. The fibrinogen coagulation test showed that the time of coagulation was increased significantly with increase in rDoenitin-1 protein concentration, and the activated partial thromboplastin time (APTT) and prothrombin time (PT) assays showed that rDoenitin-1 significantly prolonged the coagulation time of APTT, indicating that rDoenitin-1 has an anticoagulant activity . In addition, rDoenitin-1 presents a significant inhibitory activity in thrombin and cathepsin G. The hemolysis rate of rDoenitin-1 in healthy human blood cells was 4.25%, and no obvious hemolysis activity was observed. The comparison with other life stages shows that the higher expression occurs in adults, and tissue comparison indicated a higher expression in the midgut. The RNAi results indicated that interference of significantly reduced the engorgement rate and egg hatchability of , and that the engorged body weight was slightly reduced. In conclusion, the results suggested that the novel gene functions in blood-feeding of and performs various functions during feeding and reproduction of . may be a potential vaccine candidate for tick control and for developing new antithrombotic drugs in the future.
作为专性吸血的体外寄生虫,蜱在吸血过程中分泌多种抗凝血酶分子。在本研究中,从蜱中鉴定出一个名为的新型抗凝血酶基因。它具有426 bp的开放阅读框大小;编码141个氨基酸,预测分子量为15.8 kDa。纤维蛋白原凝血试验表明,随着重组Doenitin-1蛋白浓度的增加,凝血时间显著延长,活化部分凝血活酶时间(APTT)和凝血酶原时间(PT)测定表明重组Doenitin-1显著延长了APTT的凝血时间,表明重组Doenitin-1具有抗凝血活性。此外,重组Doenitin-1对凝血酶和组织蛋白酶G具有显著的抑制活性。重组Doenitin-1在健康人血细胞中的溶血率为4.25%,未观察到明显的溶血活性。与其他生命阶段的比较表明,成虫中表达较高,组织比较表明中肠中表达较高。RNA干扰结果表明,干扰显著降低了的饱血率和卵孵化率,饱虫体重略有降低。总之,结果表明该新基因在蜱的吸血过程中起作用,并在蜱的取食和繁殖过程中发挥多种功能。可能是未来蜱控制和开发新型抗血栓药物的潜在疫苗候选物。